comparemela.com

Latest Breaking News On - Stefand anker - Page 1 : comparemela.com

Empagliflozin may reduce serum uric acid in HF patients, lower mortality risk: EMPEROR-reduced trial

Germany: In patients with heart failure, hyperuricemia is a common comorbidity and is an independent predictor of advanced disease severity and increased mortality, the researchers state in a study.

EMPEROR-Preserved: Empagliflozin Scores HFpEF Breakthrough

EMPEROR-Preserved: Empagliflozin Scores HFpEF Breakthrough
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.